Mukesh Ambani-owned Reliance Life Sciences COVID-19 vaccine candidate gets approval for Phase 1 trials from SEC but requires DCGI permission to officially begin
Covid vaccine trial participants to be issued digital certificates through Co-WIN deccanherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanherald.com Daily Mail and Mail on Sunday newspapers.
The Centre on Saturday told the SC it will procure 51.6 crore Covid vaccine doses by July 31 and an additional 135 crore doses after July to fully vaccinate the country’s entire adult population
Highlights
Russia’s Sputnik V vaccine for COVID-19 has arrived in India and is likely to hit markets from next week, informed NITI Aayog member Dr VK Paul on Thursday.
It has been decided that Hyderabad-based Dr. Reddy’s Laboratories will manufacture the vaccine in India.
Russia’s Sputnik V vaccine is going to be India’s third COVID-19 vaccine, after Bharat Biotech’s Covaxin and Oxford-AstraZeneca’s Covishield.
New Delhi: Russia’s Sputnik V vaccine for COVID-19 has arrived in India and is likely to hit markets from next week, informed NITI Aayog member Dr VK Paul on Thursday (May 13, 2021) while addressing a press conference.